Results 121 to 130 of about 128,736 (321)

Thrombocytopenia and hyperthyroidism: A case report and literature review [PDF]

, 2023
Pitchaporn Yingchoncharoen, Mahmoud Abdelnabi, Jerapas Thongpiya, Alexandra Hoffman, Hira Tariq, Neha Mittal   +5 more
openalex   +1 more source

IMpower010: 5‐Year Outcomes of Atezolizumab in Japanese Patients With Resected Stage IB–IIIA Non‐Small Cell Lung Cancer

Cancer Science, EarlyView.
The global Phase 3 IMpower010 study (NCT02486718) evaluated atezolizumab versus best supportive care (BSC) after complete resection and adjuvant platinum‐based chemotherapy in patients with stage IB–IIIA non‐small cell lung cancer (NSCLC). Here, we report updated efficacy and safety results from the disease‐free survival (DFS) final and overall ...
Morihito Okada, Shunichi Sugawara, Yasutaka Watanabe, Haruhiro Saito, Toyofumi F. Chen‐Yoshikawa, Yasushi Goto, Wataru Nishio, Shizuka Nakagawa, Morihiko Hayashi, Hirotsugu Kenmotsu   +9 more
wiley   +1 more source

TSNM, Procedure Guideline for I-131 Treatment of Hyperthyroidism 2.0

, 2015
Özhan Özdoğan, Güzin Töre, Hayal Özkılıç, Metin Kır, Doğangün Yüksel   +4 more
openalex   +1 more source

2018 European Thyroid Association Guideline for the Management of Graves’ Hyperthyroidism

European Thyroid Journal, 2018
G. Kahaly, L. Bartalena, L. Hegedüs, L. Leenhardt, K. Poppe, S. Pearce   +5 more
semanticscholar   +1 more source

Pembrolizumab for Early‐Stage Triple‐Negative Breast Cancer: KEYNOTE‐522 Japan Subgroup Analysis

Cancer Science, EarlyView.
In the global, phase 3 KEYNOTE‐522 study of high‐risk early‐stage triple‐negative breast cancer (TNBC), neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab improved efficacy outcomes versus neoadjuvant chemotherapy alone. In this analysis of Japanese participants from KEYNOTE‐522, neoadjuvant pembrolizumab plus chemotherapy ...
Masato Takahashi, Hirofumi Mukai, Toshimi Takano, Koichiro Tsugawa, Kenichi Inoue, Mitsuya Itoh, Junichiro Watanabe, Yuko Tanabe, Naohito Yamamoto, Yasuo Miyoshi, Kenichi Watanabe, Toru Mukohara, Yibin Kong, Masashi Shimura, Francisco Beca, Peter Schmid, Hiroji Iwata   +16 more
wiley   +1 more source

A two-sample bidirectional Mendelian randomization analysis between telomere length and hyperthyroidism

Frontiers in Endocrinology
Backgroundhyperthyroidism characterized by low thyrotropin, highlighting complications and risks, including cardiac issues, osteoporosis, adverse pregnancy outcomes, unintentional weight loss, and increased mortality associated with untreated ...
Shiben Zhu, Ziyu Hao, Qihang Chen, Xiaoliu Liu, Wenyan Wu, Fang Zhang   +5 more
doaj   +1 more source

Advances in Our Understanding of Hyperthyroidism-associated Bone Loss [PDF]

, 2008
Mary Jane Brassill, Graham R. Williams
openalex   +1 more source

Characterization of Sesuvium sesuvioides Using High-Performance Liquid Chromatography and Validation of Its In Vivo Anti-hyperthyroidism Effect via Suppressing Oxidative Stress and Inflammatory Markers

, 2023
Muhammad Sajid-ur-Rehman, Saiqa Ishtiaq, Muhammad Sohaib Khan, Qaiser Jabeen, Fadia S. Youssef, Safwat A. Ahmed, Sameh S. Elhady, Mohamed L. Ashour   +7 more
openalex   +1 more source

Evaluating the Link Between Thyroid Function Test Results and Levothyroxine Dose in the Management of Hypothyroidism: Can We Improve Dosing Regimes?

Clinical Endocrinology, EarlyView.
ABSTRACT Introduction Over 10 million thyroid function tests (TFTs) are carried out in England each year, most requests coming from primary care. Our previous work showed that only 25% of results for patients being treated with Levothyroxine fell within the TSH/FT4 boundary circumscribing 75% of untreated individuals.
Adrian H. Heald, Lakdasa D. Premawardhana, Peter N. Taylor, Suhani Bahl, Onyebuchi E. Okosieme, Anthony A. Fryer, Antonio Bianco, Colin M. Dayan, Michael P. Stedman   +8 more
wiley   +1 more source

Hyperthyroidism‐Induced Nondiabetic Ketoacidosis: A Rare Case Report

Clinical Case Reports
Hyperthyroidism, marked by excess thyroid hormones (T4 and T3), presents with symptoms like palpitations, heat intolerance, anxiety, and weight loss despite a normal or increased appetite.
Elias Battikh, Sherif Mostafa, Hadeel Alfar, Koutaibah Obaid, Ashraf I. Ahmed, Bisher Sawaf, Dabia Al‐Mohanadi   +6 more
doaj   +1 more source